Scottish BioTech raises funds to make cancer therapies accessible
Edinburgh-based BioTech Lentitek Ltd has secured £700,000 in private funding to make cancer therapies more widely accessible. The funding comes from Equity Gap, a leading Scottish angel investment syndicate, bringing its total investment to £1m in the last six months after the firm received a £300,000 Innovate UK grant. It will be used to accelerate … Continue reading Scottish BioTech raises funds to make cancer therapies accessible
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed